<DOC>
	<DOCNO>NCT00805649</DOCNO>
	<brief_summary>The purpose study investigate efficacy combine intravitreal therapy without prior photodynamic therapy patient wet age-related macular degeneration ( AMD ) . In patient wet AMD , significant improvement vision observe combined intravitreal therapy without prior photodynamic therapy . Both pharmacological effect drug physiological effect par plana vitrectomy ( posterior vitreous detachment , liquefaction , oxygen redistribution ) may contribute long-term sustainability therapeutic benefit .</brief_summary>
	<brief_title>Combined Therapy Age-Related Macular Degeneration ( ARMD )</brief_title>
	<detailed_description>This prospective study case series include eye predominantly classic lesion ( Group 1 ; n = 52 ) eye occult lesion ( Group 2 ; n = 106 ) . Patients predominantly classic lesion receive low fluorescence photodynamic therapy ( 42 J/cm2 72 sec ) , follow , 24 hour later , 1.5 mL core par plana vitrectomy intravitreal injection dexamethasone ( 0.8 mg ) bevacizumab ( 1.25 mg ) . Patients occult lesion receive 0.4 mL core par plana vitrectomy intravitreal injection triamcinolone ( 8 mg ) bevacizumab ( 1.25 mg ) . At baseline follow-up examination , best-corrected visual acuity ( BCVA ; logMar ) , central macular thickness ( optical coherence tomography ) , intraocular pressure ( IOP ; Goldmann tonometry ) determine . In addition , need retreatment assess , adverse event monitor .</detailed_description>
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Temazepam</mesh_term>
	<criteria>Wet age relate macular degeneration Opacities lens cornea Ongoing intraocular inflammation Trauma</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>ARMD</keyword>
	<keyword>combine therapy</keyword>
	<keyword>efficacy</keyword>
	<keyword>safety</keyword>
</DOC>